Displays for a Medical Device

Abstract

Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.

1 . (canceled) 
     
     
         2 . A method of avoiding unnecessary hyperglycemic alerts, the method comprising:
 initially activating a first alert state based on one or more first criteria associated with a hyperglycemic condition;   waiting a time period before providing an output associated with the first alert state;   actively monitoring, by a processor module, data associated with the host's hyperglycemic condition during the waiting time period; and   providing an output associated with the first alert state after the waiting time period based on the data associated with the host's hyperglycemic condition meeting one or more second criteria.   
     
     
         3 . The method of  claim 2 , wherein the actively monitoring comprises determining an average glucose over a window of time. 
     
     
         4 . The method of  claim 2 , wherein the actively monitoring comprises determining an amplitude and/or direction of rate of change. 
     
     
         5 . The method of  claim 2 , wherein the actively monitoring comprises determining an amplitude and/or direction of rate of acceleration. 
     
     
         6 . The method of  claim 2 , wherein the actively monitoring comprises evaluating insulin information. 
     
     
         7 . The method of  claim 2 , wherein the actively monitoring comprises evaluating meal information or timing. 
     
     
         8 . The method of  claim 2 , wherein the waiting time period is user selectable. 
     
     
         9 . The method of  claim 2 , further comprising not providing output associated with the first alert state after the waiting time period based on the data associated with the host's hyperglycemic condition not meeting the one or more second criteria. 
     
     
         10 . The method of  claim 2 , wherein the one or more first criteria and the one or more second criteria are the same. 
     
     
         11 . The method of  claim 2 , wherein the one or more first criteria and the one or more second criteria are different. 
     
     
         12 . The method of  claim 2 , further comprising transitioning from the first alert state to an inactive alert state based on the data associated with the host's hyperglycemic condition meeting one or more second criteria. 
     
     
         13 . The method of  claim 12 , wherein the one or more first criteria and the one or more second criteria are the same. 
     
     
         14 . The method of  claim 12 , wherein the one or more first criteria and the one or more second criteria are different. 
     
     
         15 . A system for processing data, the system comprising:
 a continuous analyte sensor configured to be implanted within a body; and   sensor electronics configured to receive and process sensor data output by the sensor, the sensor electronics including a processor configured to:
 initially activate a first alert state based on one or more first criteria associated with a hyperglycemic condition; 
 wait a time period before providing an output associated with the first alert state; 
 actively monitor data associated with the host's hyperglycemic condition during the waiting time period; and 
 provide an output associated with the first alert state after the waiting time period based on the data associated with the host's hyperglycemic condition meeting one or more second criteria. 
   
     
     
         16 . The system of  claim 15 , wherein the actively monitoring comprises determining an average glucose over a window of time. 
     
     
         17 . The system of  claim 15 , wherein the actively monitoring comprises determining an amplitude and/or direction of rate of change. 
     
     
         18 . The system of  claim 15 , wherein the actively monitoring comprises determining an amplitude and/or direction of rate of acceleration.